US

Jesse Ryan Hancock

This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Jesse Ryan Hancock: Innovator in Blister Delivery Technology

Introduction

Jesse Ryan Hancock is an inventive mind based in the United States, known for his contributions to the field of medical devices. He has developed a unique patent that focuses on improving the delivery of medications through blister packaging.

Latest Patents

Hancock's notable invention is the "Controllable Rate Turbulating Nozzle." This device serves as a piercing mechanism for internally pierced blister delivery systems. The design includes a base, a piercer body, and an internal fluid path. The internal fluid path features multiple inlet channels leading to a central cavity, which connects to various delivery channels and exit openings. The cavity is constructed with angular walls and a top that generates turbulence in the fluid flow, allowing for a controllable spray, mist, drops, plume, or stream delivery. Additionally, the piercer body is equipped with a pointed lancet positioned at the center of the exit openings, designed specifically for piercing the lidstock of a formed blister.

Career Highlights

Hancock is currently employed at Mystic Pharmaceuticals, Inc., where he continues to innovate in the field of pharmaceutical delivery systems. His work focuses on enhancing the efficiency and effectiveness of medication delivery methods.

Collaborations

Throughout his career, Hancock has collaborated with notable colleagues, including Michael W. Shaw and Michael Shaw. These partnerships have contributed to the advancement of technology in the medical device sector.

Conclusion

Jesse Ryan Hancock is a dedicated inventor whose work in blister delivery technology showcases his commitment to improving healthcare solutions. His innovative designs have the potential to significantly impact the way medications are delivered to patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…